Chemed (NYSE:CHE) Sets New 12-Month High – Should You Buy?

Chemed Corporation (NYSE:CHE)’s stock price hit a new 52-week high during mid-day trading on Thursday . The company traded as high as $497.25 and last traded at $492.96, with a volume of 123949 shares trading hands. The stock had previously closed at $491.89.

Analysts Set New Price Targets

Several equities research analysts recently commented on CHE shares. Weiss Ratings raised Chemed from a “sell (d+)” rating to a “hold (c-)” rating in a research note on Wednesday, April 29th. Royal Bank Of Canada boosted their price target on Chemed from $422.00 to $436.00 and gave the company a “sector perform” rating in a research note on Monday, April 27th. Wall Street Zen cut Chemed from a “buy” rating to a “hold” rating in a report on Monday, June 8th. Zacks Research raised shares of Chemed from a “strong sell” rating to a “hold” rating in a research report on Monday, April 27th. Finally, Bank of America lifted their price objective on shares of Chemed from $450.00 to $510.00 and gave the company a “neutral” rating in a research note on Thursday, July 9th. One research analyst has rated the stock with a Buy rating and five have assigned a Hold rating to the stock. According to data from MarketBeat.com, the company has an average rating of “Hold” and an average target price of $480.25.

Chemed Stock Up 1.7%

The stock has a market cap of $6.77 billion, a price-to-earnings ratio of 27.79, a price-to-earnings-growth ratio of 1.85 and a beta of 0.52. The firm’s fifty day moving average price is $450.37 and its two-hundred day moving average price is $430.92. The company has a debt-to-equity ratio of 0.11, a current ratio of 0.85 and a quick ratio of 0.83.

Chemed (NYSE:CHE) last issued its earnings results on Thursday, April 23rd. The company reported $5.65 EPS for the quarter, beating the consensus estimate of $5.30 by $0.35. Chemed had a return on equity of 27.18% and a net margin of 10.23%.The company had revenue of $657.51 million during the quarter, compared to the consensus estimate of $659.22 million. During the same period last year, the business posted $5.63 EPS. The firm’s revenue for the quarter was up 1.6% compared to the same quarter last year. Chemed has set its FY 2026 guidance at 24.000-24.75 EPS. Sell-side analysts forecast that Chemed Corporation will post 22.67 earnings per share for the current fiscal year.

Chemed Announces Dividend

The company also recently disclosed a quarterly dividend, which was paid on Tuesday, June 16th. Stockholders of record on Thursday, May 28th were issued a dividend of $0.60 per share. The ex-dividend date was Thursday, May 28th. This represents a $2.40 annualized dividend and a dividend yield of 0.5%. Chemed’s payout ratio is currently 13.08%.

Insider Activity at Chemed

In other news, Director Andrea R. Lindell sold 1,347 shares of the company’s stock in a transaction that occurred on Tuesday, June 9th. The stock was sold at an average price of $447.33, for a total transaction of $602,553.51. Following the transaction, the director directly owned 4,578 shares of the company’s stock, valued at $2,047,876.74. This represents a 22.73% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Also, CEO Kevin J. Mcnamara sold 2,000 shares of the stock in a transaction on Friday, May 1st. The stock was sold at an average price of $421.13, for a total value of $842,260.00. Following the completion of the transaction, the chief executive officer owned 90,219 shares in the company, valued at approximately $37,993,927.47. This represents a 2.17% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. Insiders own 3.33% of the company’s stock.

Institutional Inflows and Outflows

Large investors have recently made changes to their positions in the business. Monetary Solutions Ltd bought a new stake in shares of Chemed during the fourth quarter worth about $25,000. Los Angeles Capital Management LLC bought a new position in Chemed in the 4th quarter valued at about $26,000. BOK Financial Private Wealth Inc. bought a new position in Chemed in the 4th quarter valued at about $27,000. Versant Capital Management Inc boosted its stake in Chemed by 7,500.0% during the 2nd quarter. Versant Capital Management Inc now owns 76 shares of the company’s stock valued at $35,000 after purchasing an additional 75 shares during the last quarter. Finally, Global Retirement Partners LLC boosted its stake in Chemed by 200.0% during the 4th quarter. Global Retirement Partners LLC now owns 87 shares of the company’s stock valued at $37,000 after purchasing an additional 58 shares during the last quarter. 95.85% of the stock is owned by institutional investors.

About Chemed

Chemed Corporation is a diversified provider of essential home services and healthcare solutions in the United States. Headquartered in Cincinnati, Ohio, the company operates through two principal business segments—Roto-Rooter and Vitas Healthcare. Since its founding in 1974, Chemed has built a reputation for reliability and expertise, serving both residential and commercial customers across a broad range of markets.

The Roto-Rooter segment offers a comprehensive suite of plumbing, drain cleaning and water restoration services.